Summary
About 28,000 new cases of pancreatic cancer are diagnosed yearly in the United States. The diagnosis is now made up to two months more quickly than just a few years ago, but this has had no impact on survival. In most institutions, 20-25% of patients have resectable lesions. The standard operation is still the Whipple pancreaticoduodenectomy, but many surgeons now use the pylorus preserving modification of that procedure. The operative mortality rate has fallen to <5%. The five-year survival rate after a resection for attempted cure is about 9%. Palliation requires cholecysto(docho)jejunostomy and gastrojejunostomy, which is often done prophylactically. The operative mortality rate in patients undergoing palliation is < 10% (recent UCLA experience), and the average survival is seven months.
Similar content being viewed by others
References
Singh SM, Longmire WP, Jr, Reber HA. Surgical palliation for pancreatic cancer. Ann. Surg. 1990; 212: 132–139.
Warshaw AL, Zhuo-yun G, Wittenberg J, Waltman AC. Preoperative staging and assessment of resectability of pancreatic cancer. Arch. Surg. 1990; 125: 230–236.
Falk RE, et al. Combination therapy for resectable and unresectable adenocarcinoma of the pancreas. Cancer 1986; 57: 685.
Botts JR, Broughan TU, Hermann RE. Palliative operations for pancreatic carcinoma. Am. J. Surg. 1990; 159: 72–78.
Weaver DW, Wieneck RG, Bouwman DL, et al. Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery 1987; 102: 608–614.
Reber HA, Foley KM, eds. Pancreatic cancer pain: presentation, pathogenesis and management. In: Journal of Pain and Symptom Management. New York, Elsevier, 1988; 3: 163–206, (entire issue).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Livingston, E.H., Welton, M.L. & Reher, H.A. Surgical treatment of pancreatic cancer. Int J Pancreatol 9, 153–157 (1991). https://doi.org/10.1007/BF02925591
Issue Date:
DOI: https://doi.org/10.1007/BF02925591